CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies ...

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze ...

The amniotic membrane market is estimated to stand at USD 1,510.6 million in 2024. The market is forecasted to exceed a valuation of USD 2,279.5 million by 2034, recording a CAGR of 4.2%. Amniotic ...

Rion Aesthetics, an internationally recognized regenerative aesthetics company, today announced that the U.S. Food and Drug ...

Rion Aesthetics, an internationally recognized regenerative aesthetics company, today announced that the U.S. Food and Drug Administration (FDA) has allowed an Investigational New Drug (IND) ...

Dimension Bio, a biotechnology company pioneering regenerative therapeutics, today announced the appointment of Heidi Hagen to its Board of Directors. Ms. Hagen brings over 30 years of leadership ...

According to the American Cancer Society, survivors of childhood cancer can face health problems later in their adult life.

This financing represents an important milestone for 3DBioFibR as it improves operational scale and deepens its role as a critical supplier of next-generation biomaterials. The funds will support ...

Using a newly devised, three-dimensional model to study the regeneration of nerve tissue in the nose, researchers have discovered that one type of stem cell thought to be dormant may play a more ...

DBioFibR Inc., a leading manufacturer of advanced biopolymer fibers, today announced the successful close of a $3 million equity financing round. The raise follows a string of recently signed paid par ...

A new study suggests that stem cells thought to be dormant may offer clues to why our sense of smell declines or is lost.

EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ:SNWV), a leading provider of next-generation FDA-approved wound care products, is ...